… mortality and morbidity by performing a meta-analysis of all randomized clinical trials of
the current era that compared the 2 treatment techniques in patients with multivessel disease. …

… Few studies have compared long-term outcomes of multivessel … era of bare-metal stents.
Therefore, we sought to compare long-term outcomes for MVR vs SVR using drug-eluting stents …

… incomplete revascularization (IR) with drug-eluting stent (DES), unlike with bypass grafting,
is not well established in patients with multivessel coronary artery disease (MVD). Methods …

… Randomized controlled trials comparing coronary artery bypass graft (CABG) surgery and
percutaneous coronary intervention (PCI) in the bare-metal stent era generally showed similar …

… all intermediate lesions to be stented; therefore, stent length was 85.3 mm. Stent length in this
study … Maybe, even in the new DES era, the superiority of CABG over PCI in multiple vessel …

… disease or acute myocardial infarction (MI). Technological advancement in PCI, such as the
introduction drug-eluting stents (… for patients with complex multivessel disease, leading to …

… had multivessel coronary stenting: after a mean follow-up period … stenting with those of 419
patients with multivessel stenting. … patients with multivessel Palmaz-Schatz stenting. However, …

… with multivessel coronary artery disease (MVD) who underwent percutaneous coronary
intervention with drug-eluting stents… The incidence of periprocedural MI and stent thrombosis was …

… have also reported the efficacy of DES for multivessel disease. The RESEARCH and T-…
Stent Era ARTS II The first major trial in the era of DES for the treatment of multivessel disease …

… with multivessel disease will be randomized on a 1:1 basis to either CABG or multivessel
stenting using … , a very low observed crossover rate in the initial trial period, and recent literature …